Global Dental Burs Market 2024
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
$2,400.00
A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product. The global combination products market is anticipated to reach valuation of ~USD 147,447 million by 2027, representing a CAGR of 7.1% from 2021 to 2027 as per the latest report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global combination products market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the combination products industry.
The combination products market is segmented on the basis of product, application, end user, and region. The combination products market is segmented as below:
By product:
– drug/device and biologic/device combination products
– drug/biologic combination products
– drug/device/biologic combination products
By application:
– cardiovascular diseases (CVDs)
– metabolic disorders
– oncology
– orthopedic disorders
– respiratory diseases
– wound care
– others
By end user:
– hospitals
– ambulatory surgical centers (ASCs)
– others
By region:
– region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
The report has also analysed the competitive landscape of the global combination products market with some of the key players being Abbott Laboratories, AbbVie Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cipla Limited, CosMED Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Novartis International AG, Novo Nordisk A/S, Sanofi S.A., Smith & Nephew plc, Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global combination products market.
– To classify and forecast the global combination products market based on product, application, end user, and region.
– To identify drivers and challenges for the global combination products market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global combination products market.
– To identify and analyze the profile of leading players operating in the global combination products market.
Why Choose This Report
– Gain a reliable outlook of the global combination products market forecasts from 2021 to 2027 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary
Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints
Part 5. Global market for combination products by product
5.1 Drug/device and biologic/device combination products
5.1.1 Market size and forecast
5.2 Drug/biologic combination products
5.2.1 Market size and forecast
5.3 Drug/device/biologic combination products
5.3.1 Market size and forecast
Part 6. Global market for combination products by application
6.1 Cardiovascular diseases (CVDs)
6.1.1 Market size and forecast
6.2 Metabolic disorders
6.2.1 Market size and forecast
6.3 Oncology
6.3.1 Market size and forecast
6.4 Orthopedic disorders
6.4.1 Market size and forecast
6.5 Respiratory diseases
6.5.1 Market size and forecast
6.6 Wound care
6.6.1 Market size and forecast
6.7 Others
6.7.1 Market size and forecast
Part 7. Global market for combination products by end user
7.1 Hospitals
7.1.1 Market size and forecast
7.2 Ambulatory surgical centers (ASCs)
7.2.1 Market size and forecast
7.3 Others
7.3.1 Market size and forecast
Part 8. Global market for combination products by region
8.1 Asia Pacific
8.1.1 Market size and forecast
8.2 Europe
8.2.1 Market size and forecast
8.3 North America
8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
8.4.1 Market size and forecast
Part 9. Key competitor profiles
9.1 Abbott Laboratories
9.2 AbbVie Inc.
9.3 B. Braun Melsungen AG
9.4 Becton, Dickinson and Company
9.5 Boston Scientific Corporation
9.6 Cipla Limited
9.7 CosMED Pharmaceutical Co., Ltd.
9.8 GlaxoSmithKline plc
9.9 Johnson & Johnson
9.10 Medtronic plc
9.11 Novartis International AG
9.12 Novo Nordisk A/S
9.13 Sanofi S.A.
9.14 Smith & Nephew plc
9.15 Stryker Corporation
9.16 Terumo Corporation
9.17 W. L. Gore & Associates, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY
Abbott Laboratories
AbbVie Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company
Boston Scientific Corporation
Cipla Limited
CosMED Pharmaceutical Co., Ltd.
GlaxoSmithKline plc
Johnson & Johnson
Medtronic plc
Novartis International AG
Novo Nordisk A/S
Sanofi S.A.
Smith & Nephew plc
Stryker Corporation
Terumo Corporation
W. L. Gore & Associates, Inc.
REPORT ATTRIBUTE | DETAILS |
---|---|
Base Year | 2020 |
Forecast Year | 2021-2027 |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.